Access campaignPress release
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
November 15, 2023 | France
Access campaignPress release
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023 |
Access campaign
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins...
November 7, 2023 | Switzerland
Access campaignPress release
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key...
September 30, 2023 |
Access campaign
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to...
September 12, 2023 |
Access campaign
TB medicine deal offers short-term solution, but J&J needs to do more for all affected...
July 14, 2023 |
Access campaign
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
March 31, 2023 | Switzerland
Access campaignPress release
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on...
March 23, 2023 |
Access campaign
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
November 30, 2022 | Switzerland
Access campaignPress release
United Kingdom
MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement
November 2, 2022 | IndiaUnited Kingdom
Access campaignPress release
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments...
October 28, 2022 |
Access campaign
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the...
June 17, 2022 | Switzerland
